PMDA inspection

Novocol Pharmaceutical of Canada, Inc.

PMDA inspection 5130608007434 · Canada · Suitable

Key facts

Control number 5130608007434
Manufacturing site Novocol Pharmaceutical of Canada, Inc.
Location 36 Wolseley Court Cambridge, Ontario, Canada N1R 6X3
Country Canada
Product type Pharmaceuticals
Application type New
Inspection method Remote
Inspection month Aug 1, 2024
Result Suitable
Result notified Aug 22, 2024

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)